时间：2020-07-22 08:16:40人气：8529来源： 迪拜新闻网
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)
A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
Chinese passports gaining power
(6001)人喜欢2025-08-03
LiYu Group invited to attend "Sustainable Markets Initiative" China Forum
(1267)人喜欢2025-07-31
China wins team gold for artistic swimming at World Aquatics Championships
(6008)人喜欢2025-07-29
Ancient Salt Sheep Road rejuvenates in modern Xizang
(6007)人喜欢2025-07-23
China discovers world's deepest industrial sandstone-type uranium mineralization in Xinjiang
(6016)人喜欢2025-07-19
Wang Chuqin wins men
(6015)人喜欢2025-07-15
China urges Nepal to search for missing nationals after border landslide
(6018)人喜欢2025-07-11
China launches new test satellite
(6023)人喜欢2025-07-05